Sustentabilidade Em Saúde: Uma Reflexão Sobre Dados Epidemiológicos Associados Ao Uso Indiscriminado De Medicamentos

Abstract

The present article proposes a reflection on the indiscriminate use of drugs and its social complications. To this end, an exploratory research was conducted, where it was possible to perform a historical analysis on the subject, from the records of the thalidomide effect, which culminates in discussions at the WHO Nairobi Conference in 1985, and the Brazilian public policies that followed the conference. In addition, from the pharmacovigilance records published by ANVISA, it was possible to identify the main drugs and effects registered in Brazil, since 2018, and perform a comparison from the most consumed drug classes associating the use of drugs to the increase in the average cost per hospitalization in the brazilian public healthcare system. The article brings to light the first published data regarding the consumption of Hydroxychloroquine and Azithromycin during the Covid-19 pandemic, and the health implications of the use of drugs without proven efficacy in the early treatment to the disease. The discussion of the results indicates that the indiscriminate use of drugs is a cultural problem, but it has financial implications, increasing the average cost of healthcare, and social implications, enabling the growth of multidrug-resistant organisms. Finally, strategies for the promotion of rational use adopted by ANVISA are listed.